Cepharanthine and Chemotherapy for IND-Enabling Esophageal Cancer Shows Positive Results
https://unsplash.com/photos/_jbClosDsD4

Cepharanthine and Chemotherapy for IND-Enabling Esophageal Cancer Shows Positive Results

According to a recent article, PharmaDrug Inc. revealed that their study of combining cepharanthine and chemotherapy to treat IND-enabling esophageal cancer has yielded positive results. Esophageal Cancer Esophageal cancer occurs…

Continue Reading Cepharanthine and Chemotherapy for IND-Enabling Esophageal Cancer Shows Positive Results
Adding Durvalumab to Chemotherapy Extends Survival in Patients with Advanced Biliary Tract Cancer
jarmoluk / Pixabay

Adding Durvalumab to Chemotherapy Extends Survival in Patients with Advanced Biliary Tract Cancer

According to a recent article, researchers have found that adding durvalumab to chemotherapy treatments results in prolonged survival rates in patients with advanced biliary tract cancer. Biliary Tract Cancer Biliary…

Continue Reading Adding Durvalumab to Chemotherapy Extends Survival in Patients with Advanced Biliary Tract Cancer
Adding Docetaxel to Cisplatin, 5-FU Improves Esophageal Cancer Overall Survival
source: pixabay.com

Adding Docetaxel to Cisplatin, 5-FU Improves Esophageal Cancer Overall Survival

From January 20th through the 22nd, 2022, researchers, specialists, and other stakeholders descended on the Gastrointestinal Cancers Symposium to discuss new and innovative research on gastrointestinal cancers. During the Symposium,…

Continue Reading Adding Docetaxel to Cisplatin, 5-FU Improves Esophageal Cancer Overall Survival
Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib
source: pixabay.com

Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib

According to a recent article, new evidence shows adding ibrutinib to a patient’s chemotherapy regimen may improve the longevity of younger patients with diffuse large B-cell lymphoma (DLBCL). Diffuse Large…

Continue Reading Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib

The Long Road to FDA Approval of Plinabulin and G-CSF to Prevent Chemotherapy Induced Neutropenia

BeyondSpring Pharmaceuticals has issued a press release announcing that the FDA presented the company with a complete response letter pertaining to its drug plinabulin and granulocyte colony-stimulating factor (G-CSF). The…

Continue Reading The Long Road to FDA Approval of Plinabulin and G-CSF to Prevent Chemotherapy Induced Neutropenia
Physical Fitness Improves Chemotherapy for Patients with Breast Cancer
https://pixabay.com/en/crossfit-sports-fitness-training-534615/

Physical Fitness Improves Chemotherapy for Patients with Breast Cancer

It’s no secret that physical fitness can, in many cases, improve our overall health and wellness. But could being physically fit also improve healthcare and treatment response? According to Medical…

Continue Reading Physical Fitness Improves Chemotherapy for Patients with Breast Cancer
Questions for COVID-19: Should Cancer Patients Attend Appointments?
Photo by National Cancer Institute on Unsplash

Questions for COVID-19: Should Cancer Patients Attend Appointments?

  In a period of unprecedented changes, it is understandable that people may question what their lives may look like moving forward. COVID-19 has now spread to 196 countries and…

Continue Reading Questions for COVID-19: Should Cancer Patients Attend Appointments?